Establishment and application of a CRISPR-Cas12a assisted genome-editing system in Zymomonas mobilis.
CRISPR
Cas12a
Genome engineering
In situ mutagenesis
Lactate
Zymomonas mobilis
ssDNA recombineering
Journal
Microbial cell factories
ISSN: 1475-2859
Titre abrégé: Microb Cell Fact
Pays: England
ID NLM: 101139812
Informations de publication
Date de publication:
03 Oct 2019
03 Oct 2019
Historique:
received:
01
07
2019
accepted:
26
09
2019
entrez:
5
10
2019
pubmed:
5
10
2019
medline:
9
10
2019
Statut:
epublish
Résumé
Efficient and convenient genome-editing toolkits can expedite genomic research and strain improvement for desirable phenotypes. Zymomonas mobilis is a highly efficient ethanol-producing bacterium with a small genome size and desirable industrial characteristics, which makes it a promising chassis for biorefinery and synthetic biology studies. While classical techniques for genetic manipulation are available for Z. mobilis, efficient genetic engineering toolkits enabling rapidly systematic and high-throughput genome editing in Z. mobilis are still lacking. Using Cas12a (Cpf1) from Francisella novicida, a recombinant strain with inducible cas12a expression for genome editing was constructed in Z. mobilis ZM4, which can be used to mediate RNA-guided DNA cleavage at targeted genomic loci. gRNAs were then designed targeting the replicons of native plasmids of ZM4 with about 100% curing efficiency for three native plasmids. In addition, CRISPR-Cas12a recombineering was used to promote gene deletion and insertion in one step efficiently and precisely with efficiency up to 90%. Combined with single-stranded DNA (ssDNA), CRISPR-Cas12a system was also applied to introduce minor nucleotide modification precisely into the genome with high fidelity. Furthermore, the CRISPR-Cas12a system was employed to introduce a heterologous lactate dehydrogenase into Z. mobilis with a recombinant lactate-producing strain constructed. This study applied CRISPR-Cas12a in Z. mobilis and established a genome editing tool for efficient and convenient genome engineering in Z. mobilis including plasmid curing, gene deletion and insertion, as well as nucleotide substitution, which can also be employed for metabolic engineering to help divert the carbon flux from ethanol production to other products such as lactate demonstrated in this work. The CRISPR-Cas12a system established in this study thus provides a versatile and powerful genome-editing tool in Z. mobilis for functional genomic research, strain improvement, as well as synthetic microbial chassis development for economic biochemical production.
Sections du résumé
BACKGROUND
BACKGROUND
Efficient and convenient genome-editing toolkits can expedite genomic research and strain improvement for desirable phenotypes. Zymomonas mobilis is a highly efficient ethanol-producing bacterium with a small genome size and desirable industrial characteristics, which makes it a promising chassis for biorefinery and synthetic biology studies. While classical techniques for genetic manipulation are available for Z. mobilis, efficient genetic engineering toolkits enabling rapidly systematic and high-throughput genome editing in Z. mobilis are still lacking.
RESULTS
RESULTS
Using Cas12a (Cpf1) from Francisella novicida, a recombinant strain with inducible cas12a expression for genome editing was constructed in Z. mobilis ZM4, which can be used to mediate RNA-guided DNA cleavage at targeted genomic loci. gRNAs were then designed targeting the replicons of native plasmids of ZM4 with about 100% curing efficiency for three native plasmids. In addition, CRISPR-Cas12a recombineering was used to promote gene deletion and insertion in one step efficiently and precisely with efficiency up to 90%. Combined with single-stranded DNA (ssDNA), CRISPR-Cas12a system was also applied to introduce minor nucleotide modification precisely into the genome with high fidelity. Furthermore, the CRISPR-Cas12a system was employed to introduce a heterologous lactate dehydrogenase into Z. mobilis with a recombinant lactate-producing strain constructed.
CONCLUSIONS
CONCLUSIONS
This study applied CRISPR-Cas12a in Z. mobilis and established a genome editing tool for efficient and convenient genome engineering in Z. mobilis including plasmid curing, gene deletion and insertion, as well as nucleotide substitution, which can also be employed for metabolic engineering to help divert the carbon flux from ethanol production to other products such as lactate demonstrated in this work. The CRISPR-Cas12a system established in this study thus provides a versatile and powerful genome-editing tool in Z. mobilis for functional genomic research, strain improvement, as well as synthetic microbial chassis development for economic biochemical production.
Identifiants
pubmed: 31581942
doi: 10.1186/s12934-019-1219-5
pii: 10.1186/s12934-019-1219-5
pmc: PMC6777028
doi:
Substances chimiques
RNA, Guide
0
Endonucleases
EC 3.1.-
Types de publication
Evaluation Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
162Subventions
Organisme : Key Technologies Research and Development Program
ID : 2018YFA0900300
Organisme : Key Technologies Research and Development Program
ID : 21978071
Organisme : Key Technologies Research and Development Program
ID : U1932141
Organisme : Hubei Technological Innovation Special Fund
ID : 2019AHB055
Organisme : Hubei Technological Innovation Special Fund
ID : 2018ACA149
Références
Appl Environ Microbiol. 2017 Aug 17;83(17):
pubmed: 28646112
Nat Biotechnol. 2016 Sep 08;34(9):933-941
pubmed: 27606440
J Biotechnol. 2018 Oct 20;284:27-30
pubmed: 30081040
Mol Cell. 2017 Apr 20;66(2):221-233.e4
pubmed: 28431230
PLoS One. 2018 Apr 25;13(4):e0195994
pubmed: 29694430
Science. 2016 Aug 5;353(6299):aad5147
pubmed: 27493190
Science. 1995 Jan 13;267(5195):240-3
pubmed: 17791346
Nature. 2015 Oct 1;526(7571):55-61
pubmed: 26432244
Cell. 2015 Oct 22;163(3):759-71
pubmed: 26422227
Curr Microbiol. 2018 Jan;75(1):107-115
pubmed: 29189942
Plasmid. 1984 Nov;12(3):211-4
pubmed: 6098907
BMC Microbiol. 2010 May 07;10:135
pubmed: 20459639
J Bacteriol. 2012 Dec;194(24):7008-9
pubmed: 23209250
Biosci Biotechnol Biochem. 2017 Mar;81(3):453-459
pubmed: 27900888
Mol Cell. 2016 Apr 7;62(1):137-47
pubmed: 27041224
BMC Genomics. 2009 Jan 20;10:34
pubmed: 19154596
J Appl Microbiol. 1997 Mar;82(3):379-88
pubmed: 12455903
Trends Biotechnol. 2019 Sep;37(9):960-972
pubmed: 30876702
Nat Biotechnol. 2009 Oct;27(10):893-4
pubmed: 19816441
Nat Rev Microbiol. 2017 Mar;15(3):169-182
pubmed: 28111461
J Microbiol Methods. 2003 Jul;54(1):75-9
pubmed: 12732423
Metab Eng. 2018 Jul;48:243-253
pubmed: 29906505
Sci Rep. 2016 Nov 24;6:37895
pubmed: 27883076
Physiol Rev. 2010 Jul;90(3):1103-63
pubmed: 20664080
Genome Announc. 2014 Jan 09;2(1):null
pubmed: 24407627
Biotechnol Biofuels. 2016 Sep 02;9(1):189
pubmed: 27594916
Biotechnol Lett. 2012 Oct;34(10):1825-32
pubmed: 22669340
Genome Announc. 2017 Jul 27;5(30):null
pubmed: 28751381
Nat Protoc. 2017 Apr;12(4):828-863
pubmed: 28333914
Cell. 2016 May 5;165(4):949-62
pubmed: 27114038
Synth Syst Biotechnol. 2018 Oct 03;3(3):135-149
pubmed: 30345399
Nat Commun. 2017 May 04;8:15179
pubmed: 28469274
F1000 Biol Rep. 2009 Dec 1;1:95
pubmed: 20556198
Biotechnol Biofuels. 2018 May 2;11:125
pubmed: 29743953
Appl Microbiol Biotechnol. 2011 Feb;89(3):761-9
pubmed: 20957358
Genome Announc. 2016 Apr 07;4(2):null
pubmed: 27056218
Sci Rep. 2016 Dec 21;6:39681
pubmed: 28000776
Nat Biotechnol. 2004 Dec;22(12):1567-72
pubmed: 15558047
RNA Biol. 2017 Oct 3;14(10):1286-1293
pubmed: 28136159
Cell Discov. 2017 Jun 06;3:17018
pubmed: 28607761
Biotechnol Biofuels. 2019 Mar 14;12:52
pubmed: 30911332
Cell Res. 2016 Aug;26(8):901-13
pubmed: 27444870
DNA Res. 2017 Dec 1;24(6):609-621
pubmed: 28679166
Microb Biotechnol. 2016 Nov;9(6):699-717
pubmed: 27629544
Metab Eng. 2018 Nov;50:57-73
pubmed: 29627506
Annu Rev Biochem. 2013;82:237-66
pubmed: 23495939
Methods. 2012 Jul;57(3):318-30
pubmed: 22293036
Biotechnol Biofuels. 2019 Jan 5;12:10
pubmed: 30627218
Cell. 2016 Jun 2;165(6):1493-1506
pubmed: 27238023